Patrick Y. Lu,Aslam Ansari,Parker J. Guan,John J. Xu,Vera Simonenko,Tom Zhong
申请号：
US16495294
公开号：
US20200108089A1
申请日:
2018.03.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides pharmaceutical compositions comprising the chemotherapy drug gemcitabine (GEM) and certain derivatives, a taurocholic acid (TCA) formulation, and a Histidine-Lysine Polymer (HKP) conjugate, for enhancement of RNAi cancer therapeutics.
